{
  "success": true,
  "sourceFile": "C:\\Users\\panik\\Documents\\GitHub\\Protcol2USDMv3\\input\\trial\\NCT01776840_SHINE\\NCT01776840_SHINE_SAP.pdf",
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37
  ],
  "modelUsed": "gemini-3-flash-preview",
  "sapData": {
    "analysisPopulations": [
      {
        "id": "pop_1",
        "name": "Intent-to-Treat Population",
        "text": "The ITT population includes all subjects who are randomized in the study. Efficacy analysis will be based on the ITT population.",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "ITT",
        "populationDescription": "The ITT population includes all subjects who are randomized in the study. Efficacy analysis will be based on the ITT population.",
        "criteria": "All randomized subjects"
      },
      {
        "id": "pop_2",
        "name": "Safety Analysis Set",
        "text": "The safety analysis set includes all randomized subjects who receive at least 1 dose of any study treatment (ibrutinib/placebo, bendamustine, or rituximab).",
        "populationType": "Safety",
        "instanceType": "AnalysisPopulation",
        "label": "SAF",
        "populationDescription": "The safety analysis set includes all randomized subjects who receive at least 1 dose of any study treatment (ibrutinib/placebo, bendamustine, or rituximab).",
        "criteria": "Randomized AND received >=1 dose of any study treatment"
      },
      {
        "id": "pop_3",
        "name": "Pharmacokinetics Analysis Set",
        "text": "The PK population is defined as all subjects who received at least 1 dose of ibrutinib and have at least 1 evaluable PK sample.",
        "populationType": "PK/PD",
        "instanceType": "AnalysisPopulation",
        "label": "PK",
        "populationDescription": "The PK population is defined as all subjects who received at least 1 dose of ibrutinib and have at least 1 evaluable PK sample.",
        "criteria": "Received >=1 dose of ibrutinib AND has >=1 evaluable PK sample"
      },
      {
        "id": "pop_4",
        "name": "Per-Protocol Set",
        "text": "The per-protocol set is a subset of the ITT population, excluding subjects with major protocol deviations that may impact the efficacy outcomes.",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "PP",
        "populationDescription": "The per-protocol set is a subset of the ITT population, excluding subjects with major protocol deviations that may impact the efficacy outcomes.",
        "criteria": "ITT population AND no major protocol deviations"
      }
    ],
    "characteristics": [
      {
        "id": "char_1",
        "name": "Age",
        "code": "AGE",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "Age",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Age at baseline in years"
      },
      {
        "id": "char_2",
        "name": "sMIPI Score",
        "code": "SMIPI_SCORE",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "sMIPI Score",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Simplified MCL international prognostic index score (low risk [0-3] vs. intermediate risk [4-5] vs. high risk [6-11])"
      },
      {
        "id": "char_3",
        "name": "TP53 Mutation Status",
        "code": "TP53_MUTATION_STATUS",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "TP53 Mutation Status",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Presence or absence of TP53 mutation"
      },
      {
        "id": "char_4",
        "name": "Tumor Bulk",
        "code": "TUMOR_BULK",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "Tumor Bulk",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Tumor bulk and tumor burden at baseline"
      }
    ],
    "summary": {
      "populationCount": 4,
      "characteristicCount": 4
    }
  }
}